Nestle Purina PetCare Company:企業の戦略・SWOT・財務情報

◆英語タイトル:Nestle Purina PetCare Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13299
◆発行会社(調査会社):MarketLine
◆発行日:2019年2月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Nestle Purina PetCare Company – Strategy, SWOT and Corporate Finance Report
Summary

Nestle Purina PetCare Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Nestle Purina PetCare Company (Nestle Purina), a subsidiary of Nestle, manufactures pet food products. It offers Dog Foods and Cat Foods under various brands including Alpo, Beggin, Bella, Beneful, Beyond, Busy, Frosty Paws, Just Right by Purina, Mighty Dog, Moist and Meaty and Purina Dog Chow. It also offers products under brands Fancy Feast, Friskies, Friskies Party Mix, Kit and Kaboodle, Muse Purina Cat Chow among others. The company operates 9-Square Ventures, which is focused on investing in emerging pet food and snack brand and Purina Farms, which features Purina Event Center and the Visitor’s Center and several canine and feline competition areas. The company operates in Europe, the Americas, and Asia, Oceania and Africa. Nestle Purina is headquartered in St. Louis, Missouri, the US.

Scope

- Detailed information on Nestle Purina PetCare Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Nestle Purina PetCare Company in the form of a SWOT analysis
- An in-depth view of the business model of Nestle Purina PetCare Company including a breakdown and examination of key business segments
- Intelligence on Nestle Purina PetCare Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Nestle Purina PetCare Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Nestle Purina PetCare Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Nestle Purina PetCare Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Nestle Purina PetCare Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Nestle Purina PetCare Company: Company Overview
Nestle Purina PetCare Company: Overview and Key Facts
Nestle Purina PetCare Company: Overview
Nestle Purina PetCare Company: Key Facts
Nestle Purina PetCare Company: Key Employees
Nestle Purina PetCare Company: Major Products and Services
Nestle Purina PetCare Company: Company History
Nestle Purina PetCare Company: Locations and Subsidiaries
Nestle Purina PetCare Company: Key Competitors
Nestle Purina PetCare Company: Company Analysis
Nestle Purina PetCare Company: Business Description
Nestle Purina PetCare Company: SWOT Analysis
Nestle Purina PetCare Company: SWOT Overview
Nestle Purina PetCare Company: Strengths
Nestle Purina PetCare Company: Weaknesses
Nestle Purina PetCare Company: Opportunities
Nestle Purina PetCare Company: Threats
Nestle Purina PetCare Company: Corporate Financial Deals Activity
Nestle Purina PetCare Company: Financial Deals Overview
Nestle Purina PetCare Company: Targets and Partners
Nestle Purina PetCare Company: Top Deals 2015 – 2019YTD*
Nestle Purina PetCare Company: Mergers and Acquisitions
Nestle Purina PetCare Company: Divestments
Nestle Purina PetCare Company: Recent Developments
Nestle Purina PetCare Company: News and Events Summary
Nestle Purina PetCare Company: Business Expansion
Nestle Purina PetCare Company: Contracts
Nestle Purina PetCare Company: Financial Performance
Nestle Purina PetCare Company: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Nestle Purina PetCare Company: Key Facts
Table 2: Nestle Purina PetCare Company: Key Employees
Table 3: Nestle Purina PetCare Company: Company History
Table 4: Nestle Purina PetCare Company: Locations and Subsidiaries
Table 5: Nestle Purina PetCare Company: Key Competitors
Table 6: Nestle Purina PetCare Company: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Nestle Purina PetCare Company: M&A Activity by Geography (TTM*)
Table 8: Nestle Purina PetCare Company: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: Nestle Purina PetCare Company: Targets and Partners
Table 10: Nestle Purina PetCare Company: Top Deals 2015 - 2019YTD*
Table 11: Nestle Purina PetCare Company: M&A Volume and Value Trend (2015 - YTD*2019)
Table 12: Nestle Purina PetCare Company: M&A Activity by Geography (2015 - YTD*2019)
Table 13: Nestle Purina PetCare Company: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 14: Nestle Purina PetCare Company: News and Events Summary
Table 15: Nestle Purina PetCare Company: Business Expansion
Table 16: Nestle Purina PetCare Company: Contracts
Table 17: Nestle Purina PetCare Company: Financial Performance
Table 18: Nestle Purina PetCare Company: Strategy and Operations

List of Figures
Figure 1: Nestle Purina PetCare Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Nestle Purina PetCare Company: M&A Activity by Geography (TTM*)
Figure 3: Nestle Purina PetCare Company: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: Nestle Purina PetCare Company: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: Nestle Purina PetCare Company: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: Nestle Purina PetCare Company: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[Nestle Purina PetCare Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The TJX Companies, Inc. (TJX):企業の財務・戦略的SWOT分析
    The TJX Companies, Inc. (TJX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Guess, Inc.:企業の戦略・SWOT・財務情報
    Guess, Inc. - Strategy, SWOT and Corporate Finance Report Summary Guess, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclos …
  • Artios Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Artios Pharma Ltd (Artios Pharma) is an independent company that focuses on the development of DNA Damage Response (DDR) therapies to treat cancer. The company has in-licensed its lead DDR programme, DNA polymerase theta (PolO) from Cancer Research Technology (CRT), which target proteins tha …
  • Sarossa plc-製薬・医療分野:企業M&A・提携分析
    Summary Sarossa plc (Sarossa), formerly Sarossa Capital Limited, is an investment holding and management company. The company principally makes investment in and growth and development of businesses which present opportunities for value creation. It focuses on portfolio investment in major internati …
  • Orly International, Inc.:企業の戦略・SWOT・財務情報
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Global Investment House KPSC (GLOBAL):企業の財務・戦略的SWOT分析
    Global Investment House KPSC (GLOBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BioLineRx Ltd (BLRX):医療機器:M&Aディール及び事業提携情報
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company focuses mainly on cancer and immunology. Its’s product pipeline includes BL-8040, a short peptide …
  • Triglav Group:企業の戦略・SWOT・財務分析
    Triglav Group - Strategy, SWOT and Corporate Finance Report Summary Triglav Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tobu Railway Co Ltd:企業の戦略・SWOT・財務分析
    Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Innovus Pharmaceuticals Inc (INNV):製薬・医療:M&Aディール及び事業提携情報
    Summary Innovus Pharmaceuticals Inc (Innovus Pharmaceuticals) is a pharmaceutical company that commercializes, licenses and develops over the counter and consumer healthcare products. The company’s products include non-drowsy allergy relief tablets, male fertility dietary supplements, blood sugar su …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also o …
  • Sears Canada Inc:戦略・SWOT・企業財務分析
    Sears Canada Inc - Strategy, SWOT and Corporate Finance Report Summary Sears Canada Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Keio University-製薬・医療分野:企業M&A・提携分析
    Summary Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law …
  • SHL TeleMedicine Ltd (SHLTN):医療機器:M&Aディール及び事業提携情報
    Summary SHL TeleMedicine Ltd (SHL) is a provider of advanced personal telemedicine systems and solutions. The company's staff monitors the health of patients to minimize the need for emergency intervention and hospitalization. Its product portfolio includes ECG transmitters, oximeter, and hand held …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆